Clinical trial
Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
NCT00121641
Study timeline
Study start (unknown)2005-07-01Date precision: month
Registry last updated2015-04-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
SaxagliptinDRUG · verified · RxNorm: saxagliptin
SaxagliptinDRUG · verified · RxNorm: saxagliptin
SaxagliptinDRUG · verified · RxNorm: saxagliptin
MetforminDRUG · verified · RxNorm: metformin
SaxagliptinDRUG · verified · RxNorm: saxagliptin
MetforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
HoustonTexas, United States1BostonMassachusetts, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1TorontoOntario, Canada1San AntonioTexas, United States1PittsburghPennsylvania, United States1BirminghamAlabama, United States1PortlandOregon, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00121641 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.